An update on treatment strategies for acromegaly

Expert Opinion on Pharmacotherapy
Laurence Katznelson

Abstract

Acromegaly is an insidious disease due to growth hormone (GH) hypersecretion from a pituitary adenoma, and is associated with multiple comorbidities and risk of premature mortality. To review the therapeutic goals and options for acromegaly. Literature review. Surgery is the mainstay of therapy, but a role for primary medical therapy using somatostatin analogs is described as well. Somatostatin analogs are the mainstay for medical therapy, largely in an adjuvant setting. The GH receptor antagonist is also used and may be considered in addition to the somatostatin analogs, or as second line therapy. Based on these multiple modalities of therapy, it should be possible to achieve biochemical control in almost all patients.

References

Jan 1, 1980·Clinical Endocrinology·L AlexanderR Wilkinson
Sep 1, 1994·European Journal of Endocrinology·H F VasenG P van Berge Henegouwen
Oct 1, 1994·Annals of Internal Medicine·R R GrunsteinC E Sullivan
Feb 19, 1998·The Journal of Clinical Endocrinology and Metabolism·R AbsA Beckers
Mar 17, 2000·The Journal of Clinical Endocrinology and Metabolism·A M LandoltG Wellis
Apr 20, 2000·The New England Journal of Medicine·P J TrainerR J Davis
Jun 8, 2000·The Journal of Clinical Endocrinology and Metabolism·J S PowellP U Freda
Sep 22, 2000·The Journal of Clinical Endocrinology and Metabolism·A G RenehanS M Shalet
Jul 5, 2003·The Journal of Clinical Endocrinology and Metabolism·Annamaria ColaoGaetano Lombardi
Feb 7, 2004·The Journal of Clinical Endocrinology and Metabolism·Joost van der HoekSteven W Lamberts
Feb 7, 2004·The Journal of Clinical Endocrinology and Metabolism·Ian M HoldawayGreg D Gamble
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Robert D MurrayShlomo Melmed
Sep 2, 2004·European Journal of Endocrinology·A ColaoG Lombardi
Sep 24, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·David M CookUNKNOWN AACE Acromegaly Guidelines Task Force
Oct 28, 2004·The Journal of Clinical Endocrinology and Metabolism·Massimo TerzoloAnnamaria Colao
Mar 11, 2005·European Journal of Endocrinology·Panagiotis NomikosRudolf Fahlbusch
Mar 12, 2005·Hormone Research·Paul J Jenkins
Apr 14, 2005·The Journal of Clinical Endocrinology and Metabolism·Shlomo MelmedAriel Barkan
Apr 22, 2005·The American Journal of Gastroenterology·Yutaka MatanoHiroshi Mabuchi
May 12, 2005·The Journal of Clinical Endocrinology and Metabolism·Pamela U FredaDaniel Rabinowitz
May 19, 2005·The Journal of Clinical Endocrinology and Metabolism·Frédéric CastinettiThierry Brue
Jul 19, 2005·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Laurence Katznelson
Nov 3, 2005·The Journal of Clinical Endocrinology and Metabolism·Annamaria ColaoRenato Cozzi
Dec 3, 2005·European Journal of Endocrinology·S MelmedA Giustina
Apr 4, 2006·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·A A van der KlaauwA M Pereira
May 3, 2006·Clinical Endocrinology·Jana JezkováLadislav Pecen
Sep 14, 2006·The Journal of Clinical Endocrinology and Metabolism·Adrian F DalyAlbert Beckers
Nov 2, 2006·The Journal of Clinical Endocrinology and Metabolism·Craig ParkinsonPeter J Trainer
Dec 15, 2006·The New England Journal of Medicine·Shlomo Melmed
Jan 5, 2007·The New England Journal of Medicine·Renzo ZanettiniGianni Pezzoli
Feb 27, 2007·European Journal of Endocrinology·Lisa SzeMichael Brändle
Nov 1, 2007·The Journal of Clinical Endocrinology and Metabolism·O M DekkersJ P Vandenbroucke

❮ Previous
Next ❯

Citations

Dec 21, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Lana A Del PortoAndrew H Kaye
Jan 6, 2015·Pituitary·Kristopher T KimmellNicholas F Marko
Aug 27, 2010·The Journal of Clinical Endocrinology and Metabolism·Manel Puig-DomingoSusan M Webb
Jul 1, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Medical Bulletin
P G Burney
European Journal of Endocrinology
H F VasenG P van Berge Henegouwen
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
D R Clemmons
© 2022 Meta ULC. All rights reserved